Biotech

All Articles

Gene publisher Volume laying off 131 employees

.Simply days after gene editor Tome Biosciences revealed concealed working cuts, a clearer photo is ...

Repare gives up 25% of workers as biotech standstills preclinical R&ampD

.Repare Therapy is giving up a quarter of its own staff as the oncology biotech downsize its preclin...

J &amp J files for FDA permission of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually taken yet another action toward realizing a return on its own $6....

Gain's period 1 win leads technique to prove Parkinson's medicine's worth

.Increase Therapies has specified its direct proving the effectiveness of its own Parkinson's health...

Actinogen records brand-new phase 2 data to save depression medicine

.Actinogen Medical's chances-- and also stock cost-- have rebounded somewhat coming from earlier thi...

Pfizer and Main add Quotient to multibillion-dollar equation

.Front Runner Pioneering and Pfizer have actually included Ratio right into their 10-program allianc...

Bayer markers $547M pact to press boundaries of noncoding RNA

.Bayer managers were actually keen to tension to Tough this summer that the German pharma titan's hu...

UK reveals programs to introduce 18 new clinical test centers

.Among a yearslong scientific test decline in the U.K., a brand-new public-private partnership has a...

UPDATE: Genentech telegrams 93 unemployments in The golden state after sharing plans to shutter cancer immunology investigation device

.Observing the statement of a sizable discharge round in April as well as a significant restructurin...

Neurocrine's KarXT competitor strikes in phase 2-- but simply at low dosage

.Neurocrine Biosciences has obtained its hoped-for profile page in a period 2 mental illness test, p...